metformin has been researched along with Anodontia in 1 studies
Metformin: A biguanide hypoglycemic agent used in the treatment of non-insulin-dependent diabetes mellitus not responding to dietary modification. Metformin improves glycemic control by improving insulin sensitivity and decreasing intestinal absorption of glucose. (From Martindale, The Extra Pharmacopoeia, 30th ed, p289)
metformin : A member of the class of guanidines that is biguanide the carrying two methyl substituents at position 1.
Anodontia: Congenital absence of the teeth; it may involve all (total anodontia) or only some of the teeth (partial anodontia, hypodontia), and both the deciduous and the permanent dentition, or only teeth of the permanent dentition. (Dorland, 27th ed)
| Timeframe | Studies, this research(%) | All Research% |
|---|---|---|
| pre-1990 | 0 (0.00) | 18.7374 |
| 1990's | 1 (100.00) | 18.2507 |
| 2000's | 0 (0.00) | 29.6817 |
| 2010's | 0 (0.00) | 24.3611 |
| 2020's | 0 (0.00) | 2.80 |
| Authors | Studies |
|---|---|
| Verge, CF | 1 |
| Donaghue, KC | 1 |
| Williams, PF | 1 |
| Cowell, CT | 1 |
| Silink, M | 1 |
1 other study available for metformin and Anodontia
| Article | Year |
|---|---|
Insulin-resistant diabetes during growth hormone therapy in a child with SHORT syndrome.
Topics: Abnormalities, Multiple; Anodontia; Blood Glucose; Child; Diabetes Mellitus, Lipoatrophic; Eye Abnor | 1994 |